| Penny Vanderbeek, | |
|
100 E Lancaster Ave, Wynnewood, PA 19096-3450 | |
| (484) 476-1000 | |
| (484) 476-9000 |
| Full Name | Penny Vanderbeek |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 100 E Lancaster Ave, Wynnewood, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093197949 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | SP014573 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.
› Verified 7 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Penny Vanderbeek, 100 E Lancaster Ave, Wynnewood, PA 19096-3450 Ph: (484) 476-1000 | Penny Vanderbeek, 100 E Lancaster Ave, Wynnewood, PA 19096-3450 Ph: (484) 476-1000 |
News Archive
The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure.
PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that the French Ministry of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil in France.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured venture capital investment of A$12 million from GBS Venture Partners Limited, Brandon Capital Partners and Uniseed to fund the development of its pain management drug, EMA401.
Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.
› Verified 7 days ago
Melinda R Milliken, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Lancaster Avenue, Suite 230, Wynnewood, PA 19096 Phone: 610-642-3796 | |
Jacqueline S Shapiro, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 Lancaster Ave, Suite 301, Wynnewood, PA 19096 Phone: 484-476-4650 Fax: 610-645-3577 | |
Ms. Ellen Jesse Bernstein, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 E Lancaster Ave, Suite 370, Wynnewood, PA 19096 Phone: 610-642-3005 Fax: 610-642-3057 | |
Melissa Diane Buchter, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 E Lancaster Ave, Wynnewood, PA 19096 Phone: 484-476-1000 | |
Ms. Sherrie Stiffler Freilich, RN CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, Lankenau Heart Pavilion, Mezzanine, Wynnewood, PA 19096 Phone: 484-476-1000 Fax: 484-476-9000 | |
Jacqueline Mcgee, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100e Lancaster Ave, Wynnewood, PA 19096 Phone: 484-476-1000 Fax: 484-476-9000 | |
Naomi T Barton, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave Ste 130, Wynnewood, PA 19096 Phone: 267-773-9563 |